{"id":"W3042176300","doi":"10.1016/j.kint.2020.06.024","title":"Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment","year":2020,"lang":"en","type":"article","venue":"Kidney International","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McMaster University; Impact","funders":"National Heart, Lung, and Blood Institute; BERLIN-CHEMIE; Eli Lilly Australia; NIHR Leicester Biomedical Research Centre; GlaxoSmithKline; Hong Kong Government; Gilead Sciences; Servier; Fresenius Medical Care North America; Astellas Pharma; National Institutes of Health; Indian Council of Medical Research; Menarini Group; Novo Nordisk; National Institute for Health and Care Research; Alnylam Pharmaceuticals; Akebia Therapeutics; Steno Diabetes Center Copenhagen; Sanofi; Amgen; Pfizer; Eli Lilly and Company; AstraZeneca; Ironwood Pharmaceuticals, Incorporated","keywords":"Guideline; Medicine; Executive summary; Diabetes mellitus; Intensive care medicine; Kidney disease; MEDLINE; Diabetes management; Evidence-based practice; Internal medicine; Type 2 diabetes; Alternative medicine; Political science; Business; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008706746,0.0001242442,0.0001831113,0.00009724332,0.0000137778,0.00001240157,0.0001203661,0.0000223545,0.000038932],"category_scores_gemma":[0.0001258032,0.00008749037,0.00005939464,0.000179708,0.00004037936,0.000164426,0.00009323484,0.00005261788,0.000003025168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000192042,"about_ca_system_score_gemma":0.00004304652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002333216,"about_ca_topic_score_gemma":0.000006591638,"domain_scores_codex":[0.9990588,0.00002620964,0.000296126,0.0002249128,0.0002601715,0.0001337405],"domain_scores_gemma":[0.999621,0.00005952263,0.00007952659,0.0001123425,0.00003843605,0.00008920005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001570397,0.0002594935,0.9655223,0.000104401,0.0002231,0.0000386131,0.0002455924,0.000180258,0.0005967892,0.0003143556,0.004285194,0.02807282],"study_design_scores_gemma":[0.0138048,0.001075654,0.6767528,0.005282094,0.0004527116,8.498546e-7,0.001036463,0.009597334,0.03592801,0.0004375992,0.2552287,0.0004030074],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.875845,0.005913394,0.00004473498,0.09381399,0.0008393498,0.001756,0.00005843065,0.00004530176,0.02168382],"genre_scores_gemma":[0.9926893,0.002704751,0.001889752,0.001635786,0.0001429321,0.0001259013,0.00003821109,0.0000107278,0.000762654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2887696,"threshold_uncertainty_score":0.3567754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02443741152293822,"score_gpt":0.295710383380036,"score_spread":0.2712729718570978,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}